Female lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
11 2019
Historique:
received: 16 01 2019
accepted: 25 03 2019
pubmed: 18 4 2019
medline: 2 4 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

The current etiology of interstitial cystitis/painful bladder syndrome (IC/PBS) is poorly understood and multifactorial. Recent studies suggest the female urinary microbiota (FUM) contribute to IC/PBS symptoms. This study was designed to determine if the FUM, analyzed using mid-stream voided urine samples, differs between IC/PBS patients and controls. This prospective case-controlled study compared the voided FUM of women with symptoms of urinary frequency, urgency, and bladder pain for > 6 months with the voided FUM of healthy female controls without pain. Bacterial identification was performed using 16S rRNA gene sequencing and EQUC, a validated enhanced urine culture approach. Urotype was defined by a genus present at > 50% relative abundance. If no genus was present above this threshold, the urotype was classified as 'mixed.' Group comparisons were performed for urotype and diversity measures. A mid-stream voided specimen was collected from 21 IC/PBS patients and 20 asymptomatic controls. The two groups had similar demographics. Urotypes did not differ between cohorts as assessed by either EQUC or 16S rRNA gene sequencing. We detected no significant differences between cohorts by alpha diversity. Cohorts also were not distinct using principle component analysis or hierarchical clustering. Detection by EQUC of bacterial species considered uropathogenic was high in both cohorts, but detection of these uropathogenic species did not differ between groups (p = 0.10). Enhanced culture and DNA sequencing methods provide evidence that IC/PBS symptoms may not be related to differences in the FUM, at least not its bacterial components. Future larger studies are needed to confirm this preliminary finding.

Identifiants

pubmed: 30993388
doi: 10.1007/s00192-019-03942-9
pii: 10.1007/s00192-019-03942-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1835-1842

Subventions

Organisme : NIDDK NIH HHS
ID : R01DK104718
Pays : United States
Organisme : Interstitial Cystitis Association (US)
ID : N/A
Pays : International

Références

Int Urogynecol J. 2018 Dec;29(12):1765-1771
pubmed: 30116843
J Urol. 2016 Feb;195(2):356-62
pubmed: 26410734
Am J Obstet Gynecol. 2015 Sep;213(3):347.e1-11
pubmed: 26210757
J Transl Med. 2012 Aug 28;10:174
pubmed: 22929533
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
J Clin Microbiol. 2014 Mar;52(3):871-6
pubmed: 24371246
Int Urogynecol J. 2016 May;27(5):723-33
pubmed: 26423260
mBio. 2014 Jul 08;5(4):e01283-14
pubmed: 25006228
J Urol. 2015 May;193(5):1545-53
pubmed: 25623737
Obstet Gynecol. 2017 Mar;129(3):500-506
pubmed: 28178051
J Clin Microbiol. 2013 Jul;51(7):2054-62
pubmed: 23596238
Bioinformatics. 2011 Aug 15;27(16):2194-200
pubmed: 21700674
PLoS One. 2012;7(3):e33865
pubmed: 22457796
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
J Clin Microbiol. 2012 Apr;50(4):1376-83
pubmed: 22278835
Int Urogynecol J. 2018 Dec;29(12):1797-1805
pubmed: 30267143
J Urol. 2007 Feb;177(2):450-6
pubmed: 17222607
BMC Microbiol. 2012 Sep 13;12:205
pubmed: 22974186
Front Cell Infect Microbiol. 2016 Jul 27;6:78
pubmed: 27512653

Auteurs

Larissa Bresler (L)

Department of Urology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA. LBRESLER@lumc.edu.
Department of Urology, Loyola University Medical Center, 2160 S First Ave., Maywood, IL, 60153, USA. LBRESLER@lumc.edu.

Travis K Price (TK)

Department of Microbiology and Immunology, Loyola University Chicago, Health Sciences Division, Stritch School of Medicine, Maywood, IL, 60153, USA.

Evann E Hilt (EE)

Department of Microbiology and Immunology, Loyola University Chicago, Health Sciences Division, Stritch School of Medicine, Maywood, IL, 60153, USA.

Cara Joyce (C)

Department of Public Health Sciences, Loyola University Chicago, Health Sciences Division, Stritch School of Medicine, Maywood, IL, 60153, USA.

Colleen M Fitzgerald (CM)

Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Loyola University Medical Center, Maywood, IL, 60153, USA.

Alan J Wolfe (AJ)

Department of Microbiology and Immunology, Loyola University Chicago, Health Sciences Division, Stritch School of Medicine, Maywood, IL, 60153, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH